Emory University Cancer Institute is a clinical research site located in Atlanta, Georgia, United States 30322.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Emory University Cancer Institute has participated in 1 clinical trials.
Therapeutic areas: Chronic Myeloid Leukemia.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Emory University Cancer Institute has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Emory University Cancer Institute has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia.
Emory University Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.